FDA Recall United States OngoingHistorical recordClass I
Abbott Laboratories
- Product
- Abbott Similac PM 60/40 Low Iron Infant Formula, 14.1oz. can…
- Published
- March 16, 2022
- Distribution
- Nationwide
Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
OngoingClass I
Consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants and evidence of Cronobacter sakazakii in the manufacturing facility where the product had been produced
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Abbott Similac Pro-Advance 20.6oz., 30.3oz., 34oz., and 658g plastic jar. 6 jars per case. 7oz. can. 6 cans per case. Item numbers: 6720113 6720813 6726613 6818013 6818213 6832313 Retail UPCs: 055325002499 055325002543 055325002604 055325002819 055325002833 055325003069 | Not published in this source record | 135652 cases | Batches: 32624SH00 34958SH00 25673SH00 31463SH00 31549SH00 32625SH00 32626SH00 25604K800 31454K800 35008K800 37251K800 35055SH00 35056SH00 32624SH01 32625SH01 32626SH01 |
This recall shares FDA event ID 89629 with 10 other product entries in Public Health Trace.
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States OngoingHistorical recordClass I
Responsible company: Abbott Laboratories
FDA Recall United States TerminatedTerminated: September 3, 2024Historical recordClass II
FDA Recall United States TerminatedTerminated: December 14, 2023Historical recordClass II
FDA Recall United States TerminatedTerminated: August 14, 2024Historical recordClass II
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.
According to FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
Reconnecting to the server…
We lost the connection to the server.
Your session has expired.